Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 4, 2013, Pages 498-505

  Nehra, Deepika ^a   Fallon, Erica M ^a   Carlson, Sarah J ^a   Potemkin, Alexis K ^a   Hevelone, Nathanael D ^b   Mitchell, Paul D ^a   Gura, Kathleen M ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cholestasis; lipid; neonate; parenteral nutrition; parenteral nutrition associated cholestasis

Indexed keywords

BILIRUBIN GLUCURONIDE; FISH OIL; SOYBEAN OIL EMULSION;

ARTICLE; BLOODSTREAM INFECTION; CHOLESTASIS; COMORBIDITY; DRUG DOSE COMPARISON; ENTERIC FEEDING; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

CHOLESTASIS; LIPID; NEONATE; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS;

BILIRUBIN; CHOLESTASIS; ENTERAL NUTRITION; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; HUMANS; INFANT, NEWBORN; MALE; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; SOYBEAN OIL;

GLYCINE MAX;

EID: 84879229515     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112453072     Document Type: Article

References (40)

1. Wretlind A.. Development of fat emulsions. JPEN J Parenter Enteral Nutr. 1981 ; 5 (3). 230-235
2. Edgren B, Wretlind A.. The theoretical background of the intravenous nutrition with fat emulsions. Eur Rev Nutr Diet. 1963 ; 13: 364-386
3. Chen WJ, Yeh SL, Huang PC.. Effects of fat emulsions with different fatty acid composition on plasma and hepatic lipids in rats receiving total parenteral nutrition. Clin Nutr. 1996 ; 15 (1). 24-28
4. Aksnes J, Eide TJ, Nordstrand K.. Lipid entrapment and cellular changes in the rat myocard, lung and liver after long-term parenteral nutrition with lipid emulsion: a light microscopic and ultrastructural study. APMIS. 1996 ; 104 (7-8). 515-522
5. Zaman N, Tam YK, Jewell LD, Coutts RT.. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos. 1997 ; 18 (9). 803-819
6. Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57 (3). 445-452
7. Carter BA, Shulman RJ.. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007 ; 4 (5). 277-287
8. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007 ; 62 (3). 301-306
9. Grimminger F, Wahn H, Mayer K, Kiss L, Walmrath D, Seeger W.. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med. 1997 ; 155 (2). 513-519
10. Goulet O, Ruemmele F.. Causes and management of intestinal failure in children. Gastroenterology. 2006 ; 130 (2). S16 - S28
11. Wessel JJ, Kocoshis SA.. Nutritional management of infants with short bowel syndrome. Semin Perinatol. 2007 ; 31 (2). 104-111
12. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C.. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24 (6). 345-350
13. Grummer-Strawn LM, Reinold C, Krebs NF.. Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep. 2010 ; 59 (RR-9). 1-15
14. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS.. New intrauterine growth curves based on United States data. Pediatrics. 2010 ; 125 (2). e214 - e224
15. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33 (5). 541-547
16. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int. 2009 ; 25 (1). 123-124
17. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121 (3). e678 - e686
18. Gura KM, Parsons SK, Bechard LJ, et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 ; 24 (5). 839-847
19. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
20. Clark RH, Chace DH, Spitzer AR.. Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial. Pediatrics. 2007 ; 120 (6). 1286-1296
21. Steinbach M, Clark RH, Kelleher AS, et al. Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. J Perinatol. 2008 ; 28 (2). 129-135
22. Diamond IR, de Silva NT, Tomlinson GA, et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enteral Nutr. 2011 ; 35 (5). 596-602
23. Wilmore DW, Dudrick SJ.. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA. 1968 ; 203 (10). 860-864
24. Quiros-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004 ; 145 (2). 157-163
25. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA.. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 2010 ; 34 (1). 32-37
26. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999 ; 126 (1). 28-34
27. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009 ; 19 (6). 348-353
28. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996 ; 31 (4). 604-606
29. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK.. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007 ; 27 (5). 284-290
30. Allardyce DB.. Cholestasis caused by lipid emulsions. Surg Gynecol Obstet. 1982 ; 154 (5). 641-647
31. Shin JI, Namgung R, Park MS, Lee C.. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?. Eur J Pediatr. 2008 ; 167 (2). 197-202
32. Ching YA, Gura K, Modi B, Jaksic T.. Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches. Nutr Clin Pract. 2007 ; 22 (6). 653-663
33. Btaiche IF, Khalidi N.. Parenteral nutrition-associated liver complications in children. Pharmacotherapy. 2002 ; 22 (2). 188-211
34. Buchman A.. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2002 ; 26 (5). S43 - S48
35. Kelly DA.. Liver complications of pediatric parenteral nutrition - epidemiology. Nutrition. 1998 ; 14 (1). 153-157
36. Nehra D, Fallon EM, Puder M.. The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg Clin North Am. 2011 ; 91 (3). 543-563
37. Drongowski RA, Coran AG.. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr. 1989 ; 13 (6). 586-589
38. Cober MP, Teitelbaum DH.. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010 ; 15 (3). 330-333
39. Sala-Vila A, Barbosa VM, Calder PC.. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2007 ; 10 (2). 165-174
40. Modi BP, Langer M, Ching YA, et al. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg. 2008 ; 43 (1). 20-24